Linda DeGraw
Director, Contracts Specialist
Director, Contracts Specialist
Areas of Focus
Overview
Linda DeGraw has dedicated more than 25 years to drafting, negotiating, and managing contracts in the biopharmaceutical industry, including the specialized agreements required for large, multi-center international clinical studies.
Career & Education
- Consultant to Legal Division, Warner Chilcott (now Allergan)
- Drafted and negotiated various agreements relating to the pharmaceutical industry.
- Manager, Pharmaceutical Licensing & Business Development, Warner-Lambert Company (now Pfizer)
- Evaluated licensing opportunities
- Assisted in structuring business deals
- Legal Advisor, Corporate Legal Division, Warner-Lambert Company (now Pfizer)
- Responsible for a broad range of agreements relating to research and drug development activities
- Consultant to Legal Division, Warner Chilcott (now Allergan)
- RKD Paralegal Studies, Inc., Paralegal Certificate
- Thomas Edison State University, B.S., Business Administration
- Fairleigh Dickinson University, M.B.A.
Representative Matters
- Supported contracting for numerous large, multinational, pivotal clinical studies, including site feasibility, clinical site, master services agreements, facility use, consortium, and informed consents. Recent examples include:
- Multiple, concurrent clinical trials of precision medicine therapeutics, including multinational Phase 2/3 trials involving over 80 sites in North America, Europe, and Asia.
- Multiple concurrent clinical trials of a bifunctional monoclonal antibody that targets B cells for multiple autoimmune diseases, including multinational Phase 3 trials involving over 100 sites in North America, South America, Europe, and Asia.
- Phase 2/3 gene therapy clinical trial involving approximately 12 subjects across five sites in Europe and the U.S.
- Drafted and negotiated multi-million-dollar master services agreements with global contract research organizations for large, multinational clinical studies of therapeutic, medical device, and gene therapy products.